You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-TNFSF11 (TNFSF11) Antibodies

Full name:
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 11 Antibodies (TNFSF11)
On www.antibodies-online.com are 248 Tumor Necrosis Factor (Ligand) Superfamily, Member 11 (TNFSF11) Antibodies from 29 different suppliers available. Additionally we are shipping TNFSF11 Kits (108) and TNFSF11 Proteins (53) and many more products for this protein. A total of 422 TNFSF11 products are currently listed.
Synonyms:
BTF3L1, CD254, hRANKL2, HUMBTFB, Ly109l, OCIF, ODF, Opg, OPGL, OPTB2, RANKL, sOdf, TNFRSF11B, TNFSF11, Trance
list all antibodies Gene Name GeneID UniProt
TNFSF11 690  
TNFSF11 21943 O35235
TNFSF11 117516 Q9ESE2

Show all species

Show all synonyms

Most Popular Reactivities for anti-TNFSF11 (TNFSF11) Antibodies

Select your species and application

anti-Human TNFSF11 Antibodies:

anti-Mouse (Murine) TNFSF11 Antibodies:

anti-Rat (Rattus) TNFSF11 Antibodies:

All available anti-TNFSF11 Antibodies

Go to our pre-filtered search.

Top referenced anti-TNFSF11 Antibodies

  1. Human Polyclonal TNFSF11 Primary Antibody for IF (p), IHC (p) - ABIN672696 : Yang, Li, Yang, Shen, Zou, Zhu, Zhang, Yang, Li: Efficacy and safety of echinacoside in a rat osteopenia model. in Evidence-based complementary and alternative medicine : eCAM 2013 (PubMed)
    Show all 7 references for ABIN672696

  2. Human Polyclonal TNFSF11 Primary Antibody for IF (p), IHC (p) - ABIN668556 : Zhang, Liu, Li, Bai: Mycobacterium tuberculosis 10-kDa co-chaperonin regulates the expression levels of receptor activator of nuclear factor-?B ligand and osteoprotegerin in human osteoblasts. in Experimental and therapeutic medicine 2015 (PubMed)
    Show all 5 references for ABIN668556

  3. Human Polyclonal TNFSF11 Primary Antibody for EIA, IHC (p) - ABIN500805 : Kong, Yoshida, Sarosi, Tan, Timms, Capparelli, Morony, Oliveira-dos-Santos, Van, Itie, Khoo, Wakeham, Dunstan, Lacey, Mak, Boyle, Penninger: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. in Nature 1999 (PubMed)
    Show all 4 references for ABIN500805

  4. Human Polyclonal TNFSF11 Primary Antibody for IF, ELISA - ABIN1533487 : Anderson, Maraskovsky, Billingsley, Dougall, Tometsko, Roux, Teepe, DuBose, Cosman, Galibert: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. in Nature 1997 (PubMed)
    Show all 2 references for ABIN1533487

  5. Human Monoclonal TNFSF11 Primary Antibody for ELISA (Detection), FACS - ABIN281395 : Kanamaru, Iwai, Ikeda, Nakajima, Ishikawa, Azuma: Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. in Immunology letters 2004 (PubMed)

  6. Human Polyclonal TNFSF11 Primary Antibody for EIA, WB - ABIN116279 : Grimaud, Soubigou, Couillaud, Coipeau, Moreau, Passuti, Gouin, Redini, Heymann: Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. in The American journal of pathology 2003 (PubMed)

  7. Human Monoclonal TNFSF11 Primary Antibody for WB - ABIN2668631 : Hikita, Yana, Wakeyama, Nakamura, Kadono, Oshima, Nakamura, Seiki, Tanaka: Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand. in The Journal of biological chemistry 2006 (PubMed)

More Antibodies against TNFSF11 Interaction Partners

Human Tumor Necrosis Factor (Ligand) Superfamily, Member 11 (TNFSF11) interaction partners

  1. Alendronate stimulated OPG (show TNFRSF11B Antibodies) mRNA and protein expression, but not RANKL expression, in fibroblasts from patients with aseptic loosening following total hip arthroplasty.

  2. Atorvastatin treatment reduced circulating osteoprogenitor cells and RANKL expression in T cells, and increased OPG (show TNFRSF11B Antibodies) serum levels in postmenopausal osteoporisis.

  3. Hypoxia can affect the expression of RANKL and OPG (show TNFRSF11B Antibodies) in human periodontal ligament cells

  4. Osteoprotegerin (OPG (show TNFRSF11B Antibodies)), The Endogenous Inhibitor of Receptor Activator of NF-kappaB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers

  5. expression of OPG (show TNFRSF11B Antibodies), RANK and RANKL genes exert a crucial role in the progression of avascular necrosis

  6. IL-29 (show IL29 Antibodies) directly induces RANKL expression in rheumatoid arthritis-fibroblasts like synoviocytes via MAPK (show MAPK1 Antibodies) signaling pathway.

  7. Src (show SRC Antibodies) expression showed a significantly positive linear relationship with RANK, suggesting a potential mechanism of the RANKL-RANK axis in regulating breast cancer cell differentiation and antiapoptosis.

  8. a dual action of HDFCs in osteoclastogenesis; moreover, parathyroid hormone-related protein (show PTHLH Antibodies), CSF-1 (show CSF1 Antibodies) and BMP-2 (show BMP2 Antibodies) might influence osteoclastogenesis by regulating the expression of RANKL and OPG (show TNFRSF11B Antibodies) in HDFCs

  9. the independent and positive (beta = 0.449, p = 0.004, and R(2) = 0.185) association between the OxS marker and RANKL/OPG ratio which was found in osteopenic but not in the other 2 sample groups.

  10. Despite comparable osteoprotegerin (show TNFRSF11B Antibodies) concentrations, lumbar disc herniation cases express lower RANKL than controls. Disc herniation was strongly associated with RANKL and the presence of the F allele of the VDR (show CYP27B1 Antibodies) gene.

Mouse (Murine) Tumor Necrosis Factor (Ligand) Superfamily, Member 11 (TNFSF11) interaction partners

  1. NF-kappaB (show NFKB1 Antibodies) regulates RANKL-induced osteoclast differentiation and mitochondrial biogenesis via independent mechanisms

  2. In the presence of the LentisiTNFalphaOPG vector, the mRNA expression levels of the inflammatory factors and RANKL were downregulated, as were the protein levels of TNFalpha (show TNF Antibodies)

  3. RANKL has a role in proliferation-coupled osteoclast differentiation

  4. Whole-body Rankl deletion completely abrogates tumorigenesis.

  5. a dual action of HDFCs in osteoclastogenesis; moreover, parathyroid hormone-related protein (show PTHLH Antibodies), CSF-1 (show CSF1 Antibodies) and BMP-2 (show BMP2 Antibodies) might influence osteoclastogenesis by regulating the expression of RANKL and OPG in HDFCs

  6. In palmatine-treated mice, RANKL and OPG expression decreased. In the culture supernatant of MC3T3-E1 cells, RANKL and OPG levels were significantly reduced by palmatine addition.

  7. OPG inhibits osteoclast differentiation via the MAPK (show MAPK1 Antibodies) signaling pathway.

  8. Stromal reticular cells activate lymphatic endothelial cells via RANKL and support the action of hematopoietic cell-derived lymphotoxin (show LTB Antibodies).

  9. SAA (show SAA1 Antibodies) inhibits osteoclast formation from mouse macrophages. SAA (show SAA1 Antibodies) blocks RANKL-induced osteoclastogenesis.

  10. Adseverin (show SCIN Antibodies) knockdown also suppressed the RANKL-mediated induction of nuclear factor of activated T-cell (show NFATC3 Antibodies) c1 (NFATc1 (show NFATC1 Antibodies)), which is a key transcription factor in osteoclastogenesis.

TNFSF11 Antigen Profile

Antigen Summary

This gene encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found.

Alternative names and synonyms associated with TNFSF11

  • tumor necrosis factor (ligand) superfamily, member 11 (TNFSF11) antibody
  • basic transcription factor 3 pseudogene 11 (BTF3P11) antibody
  • tumor necrosis factor (ligand) superfamily, member 11 (Tnfsf11) antibody
  • tumor necrosis factor receptor superfamily, member 11b (Tnfrsf11b) antibody
  • tumor necrosis factor receptor superfamily, member 11b (TNFRSF11B) antibody
  • BTF3L1 antibody
  • CD254 antibody
  • hRANKL2 antibody
  • HUMBTFB antibody
  • Ly109l antibody
  • OCIF antibody
  • ODF antibody
  • Opg antibody
  • OPGL antibody
  • OPTB2 antibody
  • RANKL antibody
  • sOdf antibody
  • TNFRSF11B antibody
  • TNFSF11 antibody
  • Trance antibody

Protein level used designations for TNFSF11

tumor necrosis factor (ligand) superfamily, member 11 , tumor necrosis factor ligand superfamily member 11 , Receptor activator of nuclear factor kappa-B ligand , TNF-related activation-induced cytokine , osteoclast differentiation factor , osteoprotegerin ligand , receptor activator of nuclear factor kappa B ligand , receptor activator of nuclear factor kappa-B ligand , OPG ligand , receptor activator of NF-kappaB ligand , tumor necrosis factor-related activation-induced cytokine , ODF , OPGL , TRANCE , Osteoprotegerin , tumor necrosis factor receptor superfamily member 11B , tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)

GENE ID SPECIES
467353 Pan troglodytes
513836 Bos taurus
609418 Canis lupus familiaris
699955 Macaca mulatta
100599838 Nomascus leucogenys
690 Homo sapiens
8600 Homo sapiens
21943 Mus musculus
117516 Rattus norvegicus
25341 Rattus norvegicus
378803 Gallus gallus
Selected quality suppliers for anti-TNFSF11 (TNFSF11) Antibodies
Did you look for something else?